about
The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates.Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activitySuppression of cell-cycle progression by Jun dimerization protein-2 (JDP2) involves downregulation of cyclin-A2Bioluminescence imaging of DNA synthetic phase of cell cycle in living animalsThe transcriptional co-activator PCAF regulates cdk2 activityAn intron-retaining splice variant of human cyclin A2, expressed in adult differentiated tissues, induces a G1/S cell cycle arrest in vitro.L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro.NudC deacetylation regulates mitotic progression.Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin a toxicity and carcinogenicity?PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27 Kip1.Acetylation mediates Cx43 reduction caused by electrical stimulationSIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation.CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.Substrate-specific regulation of ubiquitination by the anaphase-promoting complex.Ochratoxin a and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A.p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes.How do tumor cells respond to HDAC inhibition?Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.Acetylation of RNA processing proteins and cell cycle proteins in mitosis.Histone deacetylase 3 regulates cyclin A stability.Rescue of cell cycle progression in BRAFV600E inhibitor-resistant human melanoma by a chromatin modifier.Constraints and consequences of the emergence of amino acid repeats in eukaryotic proteins.Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle.Role of p27Kip1 as a transcriptional regulator.
P2860
Q24323898-B65B4A98-E58D-4FFB-91E7-8F452246D643Q26851623-97783C43-8338-4203-9527-B38B588C963EQ28292002-383517FD-7526-43E5-A777-4B7BCE675C7CQ28484818-76F953A8-DC35-454D-910F-7262AC7DF33DQ28592663-21E4ED2E-4A75-4D35-B049-CF1B84061B5AQ34321288-92EA7376-889B-4ED9-83A1-DCB0FDE716DFQ34472177-4657D2EF-24E4-4E88-8FA9-97D820192851Q34998873-5E9DDE3A-E8E4-43EA-A8BA-72305456C644Q35161418-47260485-EC8A-4047-868D-E729D0AB9592Q36144859-D865B376-EB59-491D-9659-B8C4462DDA6FQ36260268-8797B85A-EACF-40CD-98F9-C74E3AC32438Q37423517-AA6AF401-BF7F-496B-8CB8-36DACD34578FQ37740906-DDBC73F6-BAD3-4BF6-A7E3-55C04DD6EB45Q37824560-2170D334-8599-4A26-BE30-B99AD28D31D4Q37992020-8868E0BB-BF83-4AF7-8214-B0B19EB36C25Q38718068-7F22E14F-1DC3-443F-AD80-5DEFEFDB95AAQ38817005-1A962A7F-F49B-4D8D-8756-1CC7DDA673E8Q39244903-C84D4BD5-3190-45C8-A1B6-AFB55996589CQ42136568-0797C8DB-ADA7-4698-BC54-2AFDBEB870C3Q42622406-CD3DF1BA-F4BF-4B6C-8735-FB79D04C464BQ46103191-4BEBC44D-4589-45EA-8220-DCC6F56085CDQ47956508-C744012B-A90E-4014-8312-91DC80767698Q51371739-D430894C-8CC9-4DEE-B0A6-1A6AD6FC48B0Q55074324-6153CFCF-DCE0-4B3D-BF08-0FEE9ED5276C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Degradation of cyclin A is regulated by acetylation.
@en
Degradation of cyclin A is regulated by acetylation.
@nl
type
label
Degradation of cyclin A is regulated by acetylation.
@en
Degradation of cyclin A is regulated by acetylation.
@nl
prefLabel
Degradation of cyclin A is regulated by acetylation.
@en
Degradation of cyclin A is regulated by acetylation.
@nl
P2093
P2860
P50
P356
P1433
P1476
Degradation of cyclin A is regulated by acetylation
@en
P2093
M Vidal-Laliena
P2860
P2888
P304
P356
10.1038/ONC.2009.127
P407
P577
2009-06-01T00:00:00Z